|
T37979 |
N-Desmethyl Pimavanserin
|
AC-279 |
5-HT Receptor
|
|
N-Desmethyl Pimavanserin (AC-279) is the active metabolite of Pimavanserin, a 5-HT2A receptor inverse agonist, which is used in the treatment of sleep disorders such as insomnia. |
|
T12527L |
Mavodelpar free acid hydrochloride
|
Mavodelpar free acid hydrochloride(942594-93-6 Free base),Pparδ agonist HCl,HPP593 free acid HCl,REN001 free acid HCl |
PPAR
|
|
Mavodelpar free acid hydrochloride (Pparδ agonist HCl) is a potent PPARδ agonist. |
|
TQ0174 |
Mavorixafor
|
AMD-070 |
CXCR
|
|
|
|
T2076 |
Pimavanserin
|
ACP-103 |
5-HT Receptor
|
|
Pimavanserin (ACP-103)(ACP-103) is an effective and specific 5-HT2A receptor inverse agonist (mean pIC50: 8.7, in the cell-based functional assay). Pimavanserin is an atypical antipsychotic used in the treatment of hallu... |
|
T76690 |
Mavrilimumab
|
CAM 3001 |
Virus Protease
,
CSF-1R
|
|
Mavrilimumab (CAM 3001) is a monoclonal antibody with antiviral activity that has an affinity for the α subunit of the granulocytic-macrophage colony-stimulating factor (GM-CSF) receptor and blocks downstream intracellul... |
|
T6946 |
Pimavanserin tartrate
|
ACP-103,ACP-103 tartrate,Nuplazid,Pimavanserin |
5-HT Receptor
|
|
Pimavanserin tartrate (Nuplazid) is an effective and specific serotonin 5-HT2A inverse agonist (pIC50: 8.73), used in the therapy of psychosis associated with Parkinson's disease. |
|
T21322 |
Mavelertinib
|
PF 06747775,PFE-X775,PF-06747775,PF-7775,PF 6747775,PF6747775 |
EGFR
|
|
Mavelertinib (PF-06747775) is an orally available, selective and potent EGFR tyrosine kinase (EGFR TKI) inhibitor with inhibitory effects on T790M/L858R and T790M/Del, and can be used in the study of oncology and respira... |
|
T7670 |
Mavacoxib
|
|
COX
|
|
Mavacoxib is a selective inhibitor of cyclooxygenase-2 (COX-2) ,with Anti-Tumour activity. |
|
T6919 |
Omaveloxolone
|
RTA-408 |
Apoptosis
,
Others
,
Nrf2
,
STING
|
|
Omaveloxolone (RTA-408) (RTA-408) is a synthetic triterpenoid that activates the cytoprotective transcription factor Nrf2 and inhibits NF-κB signaling. Phase 2. |
|
T16014 |
Mavatrep
|
JNJ-39439335 |
TRP/TRPV Channel
|
|
Mavatrep (JNJ-39439335) is a selective antagonist of TRPV1 with Ki of 6.5 nM and can be used for studies about inflammatory pain. |
|
T7134 |
Mavacamten
|
MYK-461,SAR439152 |
Myosin
|
|
Mavacamten (MYK-461) is an orally bioavailable inhibitor of cardiac myosin ATPase,( IC50s of 490, 711 nM for bovine cardiac and human cardiac, respectively) |
|
TP1595 |
Human Papillomavirus (HPV) E7 protein (49-57)
|
Human Papillomavirus (HPV) E7 protein 49-57 |
|
|
Human Papillomavirus (HPV) E7 protein (49-57) is the H-2d-restricted human papillomavirus (HPV) E749-57 epitope. |
|
T11951 |
Mavoglurant racemate
|
AFQ-056 racemate |
Others
|
|
Mavoglurant is a novel, non-competitive mGlu5 receptor antagonist. Mavoglurant (racemate) is the racemate of mavoglurant. |
|
T81789 |
Miromavimab
|
M777-16-3 |
|
|
Miromavimab (M777-16-3) is a monoclonal antibody (mAb) targeting the G-II epitope within the ectodomain of the rabies virus strain ERAGP [1]. |
|
T10296 |
Mavorixafor trihydrochloride
|
AMD-070 trihydrochloride |
HIV Protease
|
|
|
|
T73088 |
Mavodelpar
|
HPP593,REN001,REN001 ; HPP593 |
Others
|
|
Mavodelpar (REN001), a selective PPARδ agonist, effectively suppresses glomerular injury and renal fibrosis. It is utilized in the research of primary mitochondrial myopathies (PMM) and long-chain fatty acid oxidation di... |
|
T61181 |
Pentagamavunon-1
|
|
Others
|
|
Pentagamavunon-1 (PGV-1) is an oral Curcumin analog that effectively induces apoptosis through multiple molecular mechanisms. It primarily targets and inhibits key angiogenic factors, including cyclooxygenase-2 (COX-2) a... |
|
TP2183 |
Large T antigen - rhesus polyomavirus 560-568
|
|
Others
|
|
Large T antigen - rhesus polyomavirus 560-568 has a peptide sequence of Ser-Glu-Phe-Leu-Leu-Glu-Lys-Arg-Ile. T antigen is required for viral DNA replication, transcription, and virion assembly. |
